Research
We run to, not from, the world’s biggest health challenges.
The journey to invention and discovery is guided by science – and inspired by patients
Our purpose is to save and improve lives for generations. Our strategy is simple: We follow the science. The path to discovery is often unclear, but we are tireless in seeking solutions for some of the world’s most difficult health challenges.
At MSD, we are particularly proud of our innovations in all research areas. In our Research Laboratories, our global employees focus on discovering and developing therapies to improve patients’ lives. Compounds discovered at MSD’s global Research Laboratories are tested in all phases of clinical research, also in Austria. Only through intensive research and continuous development of medicines can people around the world and in Austria receive state-of-the-art medicines and therapies.
Our work in numbers
people employed in research and development
people reached through our major programs and partnerships
invested in R&D in 2020
Oncology
Our mission is to deliver innovations that extend and improve the lives of people with cancer.
Vaccines
Vaccines are one of the greatest public health success stories – and we’ve been discovering, developing and delivering vaccines to help prevent disease for over 100 years.
Infectious diseases
We play an important role in discovering and developing innovative medicines and vaccines to treat and prevent infectious diseases, including HIV and Ebola.
Diabetes
We are determined to find solutions for the most serious chronic health challenges, such as cardiovascular disease and diabetes.
COVID-19
The COVID-19 pandemic is an unrivaled scientific and global health challenge. As a company with a long legacy of research in infectious diseases, we have a responsibility to help.
Discovery & development
We follow the science where we can make the greatest difference, now and in the future.
In addition to these areas of focus, we also conduct intensive research in the fields of anaesthesiology, immunology, cardiovascular diseases and infectious diseases.
AT-NON-02052, created August 2023